As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
|Videos|April 26, 2023
LogiPharma Europe 2023: Wayne Rothman Discusses Re-Imagining the End-to-End Value Chain and Delivering Positive Supply Chains
Wayne Rothman speaks about re-imagining the E2E value chain and delivering positive supply chains.
Advertisement
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Wayne Rothman, VP, Value Chain Management, Johnson & Johnson, offers his thoughts on re-imaginging the end-to-end (E2E) value chain and delivering positive supply chains.
Advertisement
Related to this article
LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.
Cardinal Health and McKesson moved to extend CVS Health distribution deals through June 2032, retaining their largest customer pending final contracts.
Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.
In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
Episode 3 of Supply Chain Signal examines the Aug. 31 MFN agreements with nine mid-size manufacturers, the GENEROUS Medicaid model and whether pricing, trade and manufacturing policy now add up to a new pharma operating model.
Cencora's Ameer Ali on the operational lift behind the 12-digit NDC shift, the readiness gap across manufacturers and what's at stake for product flow if systems aren't ready in time.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cardinal Health, McKesson Extend CVS Distribution Deals to 2032
2
What to Watch at LogiPharma: Resilience, Practical AI and New Peer Formats
3
How the GLP-1 Boom Stress-Tests the Pharma Cold Chain
4
Doceree CEO: AI Should Extend the Field Force, Not Replace It
5